Exane Derivatives’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.18K | Sell |
2
-241
| -99% | -$142K | ﹤0.01% | 491 |
|
|
2022
Q1 | $170K | Sell |
243
-275
| -53% | -$192K | 0.05% | 377 |
|
|
2021
Q4 | $327K | Buy |
518
+248
| +92% | +$157K | 0.08% | 249 |
|
|
2021
Q3 | $163K | Sell |
270
-198
| -42% | -$120K | 0.04% | 428 |
|
|
2021
Q2 | $270K | Buy |
468
+93
| +25% | +$53.7K | 0.06% | 309 |
|
|
2021
Q1 | $177K | Buy |
375
+27
| +8% | +$12.8K | 0.05% | 312 |
|
|
2020
Q4 | $168K | Buy |
348
+155
| +80% | +$74.9K | 0.05% | 327 |
|
|
2020
Q3 | $108K | Buy |
193
+192
| +19,200% | +$107K | 0.03% | 277 |
|
|
2020
Q2 | $624 | Sell |
1
-1,217
| -100% | -$759K | ﹤0.01% | 570 |
|
|
2020
Q1 | $595K | Sell |
1,218
-479
| -28% | -$234K | 0.17% | 99 |
|
|
2019
Q4 | $663K | Buy |
+1,697
| New | +$663K | 0.12% | 125 |
|
|
2017
Q1 | – | Sell |
-4
| Closed | -$1.47K | – | 611 |
|
|
2016
Q4 | $1.47K | Sell |
4
-14
| -78% | -$5.14K | ﹤0.01% | 404 |
|
|
2016
Q3 | $7.24K | Sell |
18
-47
| -72% | -$18.9K | ﹤0.01% | 378 |
|
|
2016
Q2 | $22.7K | Buy |
65
+48
| +282% | +$16.8K | ﹤0.01% | 321 |
|
|
2016
Q1 | $6.13K | Hold |
17
| – | – | ﹤0.01% | 388 |
|
|
2015
Q4 | $9.23K | Hold |
17
| – | – | ﹤0.01% | 298 |
|
|
2015
Q3 | $7.91K | Sell |
17
-98
| -85% | -$45.6K | ﹤0.01% | 314 |
|
|
2015
Q2 | $58.7K | Hold |
115
| – | – | 0.01% | 243 |
|
|
2015
Q1 | $51.9K | Buy |
115
+3
| +3% | +$1.35K | 0.01% | 274 |
|
|
2014
Q4 | $45.9K | Buy |
+112
| New | +$45.9K | 0.01% | 289 |
|